文献速递关节外科

金属对金属全髋关节置换术后假性肿瘤与感染并发症的关系

The relationship between pseudotumours and infected complications in patients who have undergone metal-on-metal total hip arthroplasty.
PubMed 文献 · Bone Joint J · 2024-06-01

该回顾性研究纳入328例金属对金属全髋关节置换术后行金属伪影减少序列MRI且有至少两年随访的患者,评估假性肿瘤病史与假体周围关节感染率的关系,并建立提示感染的ESR和CRP阈值。假性肿瘤病史与PJI相关(OR 4.36),有假性肿瘤病史患者的ESR和CRP最佳诊断界值分别为33.1 mm/hr和7.37 mg/dl,高于无假性肿瘤病史患者的24.5 mm/hr和1.88 mg/dl。作者认为欧洲骨与关节感染学会发布的ESR和CRP界值可能不适用于有假性肿瘤病史的患者。

要点

  • 有假性肿瘤病史患者PJI率为14.7%(15/102),高于无假性肿瘤病史患者的5.3%(12/226)(p=0.008)。
  • 假性肿瘤病史与PJI相关,OR 4.36(95%CI 1.77至11.3),p=0.002。
  • 有假性肿瘤病史患者ESR和CRP最佳诊断界值分别为33.1 mm/hr和7.37 mg/dl。

核心结论

  • 金属对金属全髋关节置换术后有假性肿瘤病史的患者感染可能性高于无假性肿瘤病史者。
  • 对这些患者应高度怀疑感染,但欧洲骨与关节感染学会发布的ESR和CRP界值可能不适用于有假性肿瘤病史的患者。
  • 有假性肿瘤病史患者提示PJI的ESR和CRP水平可能高于无假性肿瘤病史患者。
  • 作者强烈推荐对这些患者进行额外检查如关节穿刺,除非临床怀疑和实验室标志物均低。

研究设计与样本

  • 回顾性识别2000年8月至2014年3月间1,171例金属对金属全髋关节置换患者。
  • 其中328例接受金属伪影减少序列MRI并有至少两年临床随访且符合纳入标准。
  • 收集人口学资料、手术指征、侧别、所用植入物、假性肿瘤病史及术前ESR(mm/hr)和CRP(mg/dl)水平。
  • 采用多因素逻辑回归评估PJI与假性肿瘤病史的关系,并绘制受试者工作特征曲线评估ESR和CRP对翻修手术患者感染的诊断能力。

主要发现

  • 所有识别出的金属对金属全髋关节置换患者PJI率为3.5%(41/1,171),平均随访10.9年(2.0至20.4)。
  • 最终队列中PJI率为8.2%(27/328),平均随访12.2年(2.3至20.4)。
  • 队列中31.1%(102/328)有假性肿瘤病史。
  • 有假性肿瘤病史患者PJI率为14.7%(15/102),高于无假性肿瘤病史患者的5.3%(12/226)(p=0.008)。
  • 逻辑回归分析显示假性肿瘤病史与PJI相关,OR 4.36(95%CI 1.77至11.3),p=0.002。

关键数值与推荐

  • 有假性肿瘤病史患者PJI的ESR最佳诊断界值为33.1 mm/hr,无假性肿瘤病史患者为24.5 mm/hr。
  • 有假性肿瘤病史患者PJI的CRP最佳诊断界值为7.37 mg/dl,无假性肿瘤病史患者为1.88 mg/dl。

临床怎么用

  • 作者认为对有假性肿瘤病史的患者应高度怀疑感染。
  • 作者认为欧洲骨与关节感染学会发布的ESR和CRP界值可能不适用于有假性肿瘤病史的患者。
  • 作者强烈推荐对有假性肿瘤病史的患者进行额外检查如关节穿刺,除非临床怀疑和实验室标志物均低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: This study aims to assess the relationship between history of pseudotumour formation secondary to metal-on-metal (MoM) implants and periprosthetic joint infection (PJI) rate, as well as establish ESR and CRP thresholds that are suggestive of infection in these patients. We hypothesized that patients with a pseudotumour were at increased risk of infection. METHODS: A total of 1,171 total hip arthroplasty (THA) patients with MoM articulations from August 2000 to March 2014 were retrospectively identified. Of those, 328 patients underwent metal artefact reduction sequence MRI and had minimum two years' clinical follow-up, and met our inclusion criteria. Data collected included demographic details, surgical indication, laterality, implants used, history of pseudotumour, and their corresponding preoperative ESR (mm/hr) and CRP (mg/dl) levels. Multivariate logistic regression modelling was used to evaluate PJI and history of pseudotumour, and receiver operating characteristic curves were created to assess the diagnostic capabilities of ESR and CRP to determine the presence of infection in patients undergoing revision surgery. RESULTS: The rate of PJI for all identified MoM THAs was 3.5% (41/1,171), with a mean follow-up of 10.9 years (2.0 to 20.4). Of the patients included in the final cohort, 8.2% (27/328) had PJI, with a mean follow-up of 12.2 years (2.3 to 20.4). Among this cohort, 31.1% (102/328) had a history of pseudotumour. The rate of PJI in these patients was 14.7% (15/102), which was greater than those without pseudotumour, 5.3% (12/226) (p = 0.008). Additionally, logistic regression analysis showed an association between history of pseudotumour and PJI (odds ratio 4.36 (95% confidence interval 1.77 to 11.3); p = 0.002). Optimal diagnostic cutoffs for PJI in patients with history of pseudotumour versus those without were 33.1 mm/hr and 24.5 mm/hr for ESR and 7.37 mg/dl and 1.88 mg/dl for CRP, respectively. CONCLUSION: Patients with history of pseudotumour secondary to MoM THA had a higher likelihood of infection than those without. While suspicion of infection should be high for these patients, ESR and CRP cutoffs published by the European Bone and Joint Infection Society may not be appropriate for patients with a history of pseudotumour, as ESR and CRP levels suggestive of PJI are likely to be higher than for those without a pseudotumour. Additional investigation, such as aspiration, is highly recommended for these patients unless clinical suspicion and laboratory markers are low.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Leal J, Holland CT, Cochrane NH, et al. The relationship between pseudotumours and infected complications in patients who have undergone metal-on-metal total hip arthroplasty. Bone Joint J. 2024. PMID: 38821507. doi:10.1302/0301-620X.106B6.BJJ-2023-1370.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。